Certolizumab pegol
- Level
- Commodity
- Parent
- 51202400
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51202406This classification denotes a monoclonal antibody, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UMD07X179E. European Medicines Agency schedules Certolizumab pegol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25423. Certolizumab pegol generally arises in the molecular formula C19H30N5O8S(C2H4O)N(C2H4O)N. The term CERTOLIZUMAB PEGOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 18, No. 3, 2004, list 52.) Most nations, for tariff and trade purposes, schedule certolizumab pegol under HS 30021091 and SITC 54163. Certolizumab pegol bears US NLM identifiers UMLS ID C1872109 and NCI Concept Code C80972. SMILES: As of Q4 2014, CERTOLIZUMAB PEGOL remains US FDA's Preferred Term for this commodity.
Same parent
Under 51202400 · 21Activities that produce or sell this
KBLI · 8Inherited from family 51200000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.